Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1515
-
Total 13F shares, excl. options
-
975,372,838
-
Shares change
-
+79,464,516
-
Total reported value, excl. options
-
$66,220,816,545
-
Value change
-
+$5,353,818,575
-
Put/Call ratio
-
1.57%
-
Number of buys
-
700
-
Number of sells
-
-855
-
Price
-
$67.92
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2017
1,769 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q1 2017.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,515 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 975,372,838 shares
of 1,240,722,841 outstanding shares and own 78.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (102,969,463 shares), VANGUARD GROUP INC (90,693,263 shares), STATE STREET CORP (60,006,200 shares), Bank of New York Mellon Corp (30,570,798 shares), FMR LLC (22,779,298 shares), Capital Research Global Investors (21,474,531 shares), Invesco Ltd. (18,153,295 shares), PARNASSUS INVESTMENTS /CA (16,726,150 shares), NORTHERN TRUST CORP (16,313,696 shares), and Temasek Holdings (Private) Ltd (14,444,216 shares).
This table shows the top 1515 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.